Las Vegas, NV -- (SBWIRE) -- 12/09/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Rubicon Minerals Corp. (USA) (NYSEMKT:RBY),Physicians Realty Trust (NYSE:DOC), Glu Mobile Inc. (NASDAQ:GLUU), BioTelemetry Inc (NASDAQ:BEAT)
Rubicon Minerals Corp. (USA) (NYSEMKT:RBY) managed to keep its fall at -1.04% on above-normal volume of 1.72M shares. The stock settled at $0.817 after floating in a range of $0.78 to $0.87. Its latest price has reached market capitalization of $236.11 million. Its 52-week range has been $0.78 to $2.95. Rubicon Minerals Corporation (Rubicon) is a mineral exploration company engaged in the acquisition, exploration and development of gold and base-metal exploration properties both through Company funded and partner-funded exploration. It is also involved in the investment in other mineral exploration and resource companies. It controls over 65,000 acres of exploration ground in the Red Lake gold camp, in the province of Ontario. Its main focus is on advanced exploration and development of its 100% owned Phoenix Gold Property.
Has RBY Found The Bottom and Ready To Move Up? Find Out Here
Physicians Realty Trust (NYSE:DOC) traded up on a volume of 1.70 million, higher than its standard daily volume. Shares have gained 1.48% to $11.68. Over the last twelve months, the stock has gained 1.57% and faced a worst price of $11. Physicians Realty Trustis a real estate investment trust (REIT). The Company is a self-managed healthcare real estate company.
For How Long DOC’s Gloss will Attract Investors? Find out via this report
Glu Mobile Inc. (NASDAQ:GLUU) settled -2.01% lower at $3.42 on below -normal volume of 1.67M shares during the last trading day. The stock has its 12-month high at $4.14 and 52-week low price was $2. It traded in a range of $3.42 to $3.58 during the last trading day. Glu Mobile Inc. (Glu) designs, markets and sells mobile games. The Company has developed and published a portfolio of action/adventure and casual games designed to appeal to a cross section of the users of smartphones and tablet devices who purchase its games through direct-to-consumer digital storefronts, as well as users of feature phones served by wireless carriers and other distributors. It creates games based on its own original brands, as well as third-party licensed brands. Its original games include Big Time Gangsta, Blood & Glory, Bug Village, Contract Killer, Contract Killer: Zombies, Eternity Warriors, Frontline Commando, Gun Bros, Men vs. Machines, Stardom:
Will GLUU Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, BioTelemetry Inc (NASDAQ:BEAT) was down on high volume, trading at a volume of 1.64M versus its average daily volume of 830,357.00 shares. At $7.22, the stock has attained market capitalization of 185.95 million. BioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment’s principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting.
Why Should Investors Buy BEAT After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)